| Literature DB >> 29688811 |
Megan Cross1, Sonja Biberacher1,2, Suk-Youl Park3, Siji Rajan1, Pasi Korhonen4, Robin B Gasser4, Jeong-Sun Kim5, Mark J Coster1, Andreas Hofmann1,4,6.
Abstract
The opportunistic bacterium Pseudomonas aeruginosa has been recognized as an important pathogen of clinical relevance and is a leading cause of hospital-acquired infections. The presence of a glycolytic enzyme in Pseudomonas, which is known to be inhibited by trehalose 6-phosphate (T6P) in other organisms, suggests that these bacteria may be vulnerable to the detrimental effects of intracellular T6P accumulation. In the present study, we explored the structural and functional properties of trehalose 6-phosphate phosphatase (TPP) in P. aeruginosa in support of future target-based drug discovery. A survey of genomes revealed the existence of 2 TPP genes with either chromosomal or extrachromosomal location. Both TPPs were produced as recombinant proteins, and characterization of their enzymatic properties confirmed specific, magnesium-dependent catalytic hydrolysis of T6P. The 3-dimensional crystal structure of the chromosomal TPP revealed a protein dimer arising through β-sheet expansion of the individual monomers, which possess the overall fold of halo-acid dehydrogenases.-Cross, M., Biberacher, S., Park, S.-Y., Rajan, S., Korhonen, P., Gasser, R. B., Kim, J.-S., Coster, M. J., Hofmann, A. Trehalose 6-phosphate phosphatases of Pseudomonas aeruginosa.Entities:
Keywords: drug discovery; enzyme activity; halo-acid dehydrogenase; multidrug resistance; protein structure–function
Mesh:
Substances:
Year: 2018 PMID: 29688811 DOI: 10.1096/fj.201800500R
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191